###begin article-title 0
###xml 60 64 <span type="species:ncbi:10090">mice</span>
TLR2 modulates inflammation in zymosan-induced arthritis in mice
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 1244 1252 1241 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1278 1285 1275 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 164 170 <span type="species:ncbi:10090">murine</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 639 643 <span type="species:ncbi:10090">mice</span>
###xml 756 760 <span type="species:ncbi:10090">mice</span>
###xml 844 848 <span type="species:ncbi:10090">mice</span>
The interplay between the innate and acquired immune systems in chronic inflammation is not well documented. We have investigated the mechanisms of inflammation in murine zymosan-induced arthritis (ZIA) in the light of recent data on the roles of Toll-like receptor 2 (TLR2) and Dectin-1 in the activation of monocyte/macrophages by zymosan. The severity of inflammation, joint histology, lymphocyte proliferation and antibody production in response to zymosan were analyzed in mice deficient in TLR2 and complement C3, and the effects of Dectin-1 inhibition by laminarin were studied. In comparison with wild-type animals, TLR2-deficient mice showed a significant decrease in the early (day 1) and late phases (day 24) of joint inflammation. C3-deficient mice showed no differences in technetium uptake or histological scoring. TLR2-deficient mice also showed a significant decrease in lymph node cell proliferation in response to zymosan and a lower IgG antibody response to zymosan at day 25 in comparison with wild-type controls, indicating that TLR2 signalling has a role in the development of acquired immune responses to zymosan. Although laminarin, a soluble beta-glucan, was able to significantly inhibit zymosan uptake by macrophages in vitro, it had no effect on ZIA in vivo. These results show that ZIA is more prolonged than was originally described and involves both the innate and acquired immune pathways. C3 does not seem to have a major role in this model of joint inflammation.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 48 72 48 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 131 139 131 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 279 280 279 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 768 769 768 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 48 72 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
Zymosan, a polysaccharide from the cell wall of Saccharomyces cerevisiae, is composed primarily of glucan and mannan residues [1]. In vitro, it has served as a model for the study of innate immune responses, because it is capable of stimulating inflammatory cytokine production [2] and can activate complement in the absence of immunoglobulins [3]. Zymosan is recognized and phagocytosed principally by monocytes and macrophages and leads to cellular activation [4]. Zymosan-induced arthritis (ZIA) in mice was first described by Keystone in 1977 [5]. Arthritis was induced by intra-articular injection of zymosan and was thought to be mediated by activation of the alternative pathway of complement and the release of lysosomal hydrolases from activated macrophages [6].
###end p 4
###begin p 5
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 470 471 470 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 760 761 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 834 843 830 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 886 888 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 889 891 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 367 372 <span type="species:ncbi:9606">human</span>
The recent discovery of pattern recognition receptors and their role in innate immunity has led to a re-evaluation of our concepts of zymosan-induced inflammation. Toll-like receptors (TLRs) are a family of type 1 transmembrane proteins that consists of an extracellular leucine-rich repeat domain and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin 1 (IL-1) receptor [7]. The ligands of TLR2 include lipopeptides and peptidoglycan [8,9], and TLR2 is a receptor for zymosan, acting in collaboration with CD14 and TLR6 [2,10]. Ligand binding to TLRs induces the activation of NF-kappaB and the production of the inflammatory cytokines IL-1, IL-6, IL-8, and IL-18 as well as the expression of the co-stimulatory molecule B7.1 [7]. Additionally, zymosan is able to induce maturation of dendritic cells in vitro and to stimulate their production of IL-2 [11,12], providing evidence for a link between the innate and the adaptive immune responses.
###end p 5
###begin p 6
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 459 461 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 500 525 500 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 529 546 529 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Candida albicans </italic>
###xml 627 629 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 500 524 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 529 545 <span type="species:ncbi:5476">Candida albicans</span>
The inflammatory response triggered by zymosan is linked to its phagocytosis, a process that is mediated by a set of different receptors from the TLRs. The non-opsonic recognition of zymosan by macrophages is mediated by Dectin-1. Dectin-1 is a type 2 membrane receptor with an extracellular C-type lectin-like domain fold and a cytoplasmic immunoreceptor tyrosine-based activation motif [13] and is expressed on macrophages, dendritic cells and neutrophils [14-16]. Dectin-1 mediates the binding of Saccharomyces cerevisiae and Candida albicans in a beta-glucan-dependent manner and may also have a pro-inflammatory function [17].
###end p 6
###begin p 7
In the light of the above findings, we have re-investigated ZIA to elucidate the roles of the innate and adaptive immune responses in this model and to compare the effects of TLR2 deficiency and complement C3 deficiency. The role of Dectin-1 in zymosan-induced inflammation was also investigated. Our results indicate that TLR2 is the major pathway of pro-inflammatory signalling in ZIA and is necessary for the development of specific immune responses to zymosan.
###end p 7
###begin title 8
Materials and methods
###end title 8
###begin title 9
Animals
###end title 9
###begin p 10
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 474 478 474 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 484 488 484 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
C3-deficient mice (C3-/-) on a C57bl/6 background were generated by Professor M Botto [18]. TLR2-deficient mice (TLR2-/-) on a C57bl/6 background were provided by Dr Kiyoshi Takeda (Department of Host Defense, Research Institute for Microbial Diseases, Osaka University) [19]. Wild-type (WT) C57bl/6 mice were purchased from Charles River (L'Arbresle, France). All mice were bred in our animal house facility. Double knockout and double WT mice were generated by mating TLR2-/- and C3-/- mice. The genotypes of all mice used were confirmed by polymerase chain reaction analysis of genomic DNA extracted from mice tails. The primer sequences used were as follows: TLR2 sense, 5' -GTTCTCCCAGCATTTAAAATCATT-3' ; TLR2 antisense, 5' -GTCTCCAGTTTGGGAAAAGAACC-3' ; TLR2 NEO antisense, 5' -CGACACAGCTGCGCAAGCAAC-3' ; C3 sense, 5' -CTTCATAGACTGCTGCAACCA-3' ; C3 antisense, 5' -AACCAGCTCTGTGGGAAGTG-3' ; C3 NEO antisense, 5' -AAGGGACTGGCTGCTATTGG-3'.
###end p 10
###begin title 11
Induction of ZIA
###end title 11
###begin p 12
###xml 15 40 15 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 15 39 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Zymosan A from Saccharomyces cerevisiae (Sigma, St Louis, MO, USA) (300 mg) was resuspended in 10 ml of endotoxin-free saline, boiled and homogenized by sonic emulsification. The suspension was autoclaved and stored in aliquots at -20degreesC. Arthritis was induced by intra-articular injection of 180 mug (6 mul) of zymosan through the suprapatellar ligament into the joint cavity. In specified experiments, the contralateral knee was injected with an equal amount of sterile saline (6 mul) as control.
###end p 12
###begin p 13
Laminarin was co-injected at a dose of either 500 mug or 100 mug together with 180 mug of zymosan into the knee joint.
###end p 13
###begin p 14
Approval was obtained from the local animal health committee for these experiments.
###end p 14
###begin title 15
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Isotopic quantification of joint inflammation in vivo
###end title 15
###begin p 16
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 245 248 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 365 368 364 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 412 415 411 414 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 85 89 <span type="species:ncbi:10090">Mice</span>
Joint inflammation was measured by 99mTc uptake in the knee joint as described [20]. Mice were sedated by the intra-peritoneal administration of sodium pentobarbital (50 mg/kg) and then injected subcutaneously in the neck region with 10 muCi of 99mTc. The accumulation of the isotope in the knee was determined by external gamma-counting after 15 min. The ratio of 99mTc uptake in the inflamed arthritic knee to 99mTc uptake in the contralateral control knee was calculated. A ratio higher than 1.1:1 indicated joint inflammation.
###end p 16
###begin title 17
Histological grading of arthritis
###end title 17
###begin p 18
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed at day 8 and at day 25. Knees were dissected and fixed for 2 weeks in 10% buffered formalin. Fixed tissues were decalcified for 2 weeks in 15% EDTA, dehydrated and embedded in paraffin. Sagittal sections (5 mum) of the whole knee joint were stained with safranin-O and counterstained with fast green/iron hematoxylin. Histological sections were graded by two observers unaware of animal genotype or treatment. Synovial cell infiltrate and exudate were scored from 0 (no cells) to 6 (maximum number of inflammatory cells). Cartilage proteoglycan depletion (damage), reflected by a loss of safranin-O staining intensity, was scored on a scale from 0 (fully stained cartilage) to 6 (totally unstained cartilage) in proportion to severity. For each histopathological measure the score (mean +/- SEM) of all slides was calculated.
###end p 18
###begin title 19
T cell proliferation assay
###end title 19
###begin p 20
###xml 264 266 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed in accordance with the experimental protocol. Inguinal lymph nodes were removed and single-cell suspensions were incubated in RPMI supplemented with 2-mercaptoethanol, penicillin, streptomycin and 1% autologous serum. Lymph node cells (LNC; 4 x 105 per 200 mul per well) were plated in 96-well flat-bottomed plates and stimulated with zymosan at specified concentrations. Concanavalin A at 4 mug/ml was used as non-specific mitogen.
###end p 20
###begin p 21
###xml 60 61 54 55 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 69 70 63 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 171 172 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
The cells were incubated for 48 hours at 37degreesC in 5% CO2, then [3H]thymidine (1 muCi per well) was added to the cultures for 18 hours. The cells were harvested, and [3H]thymidine uptake was measured with a beta scintillation counter.
###end p 21
###begin title 22
###xml 45 53 41 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Determination of interferon-gamma production in vitro
###end title 22
###begin p 23
###xml 273 279 <span type="species:ncbi:10090">murine</span>
Culture supernatants from LNC cultured with or without 4 mug/ml zymosan were harvested after 72 hours for determination of interferon (IFN)-gamma levels. Quantification of cytokine production was performed with an enzyme-linked immunosorbent assay (ELISA) kit specific for murine IFN-gamma (Amersham Pharmacia, Dubendorf, Switzerland).
###end p 23
###begin title 24
TLR2 immunohistochemistry
###end title 24
###begin p 25
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 226 230 226 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
Immunohistochemistry was performed with affinity purified anti-mouse TLR2 antibody (clone 6C2; eBioscience, San Diego, CA, USA). Specificity of the antibody was tested on bone marrow cells derived from c57bl/6 TLR2+/+ and TLR2-/- mice.
###end p 25
###begin p 26
Dissected knees were embedded in Tissue-Tek OCT, then immediately frozen in precooled hexane and stored at -70degreesC until use. Sections 7 mum thick were cut on a motor-driven Leica cryostat with a retraction microtome and a tungsten carbide knife at a cabinet temperature of -25degreesC and mounted on Menzel Super Frost Color glass slides.
###end p 26
###begin title 27
Phagocytosis assay
###end title 27
###begin p 28
###xml 23 25 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 30 32 30 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 204 206 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 377 378 370 371 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
RAW 264.7 cells (5 x 105 to 106 per chamber) were plated on a Lab-Tek II Chamber Slide system (Nalge Nunc International). After adherence, cells were either preincubated with 100 or 500 mug/ml laminarin [21] for 20 min followed by the addition of 25 zymosan particles per cell, or laminarin was co-administrated with zymosan. After incubation for 3 hours at 37degreesC in 5% CO2, cells were washed twice with PBS and fixed for 10 min in acetone. Cell-bound and phagocytosed particles were stained by periodic acid Schiff, a stain specific for insoluble glucose polymers, and quantified by light microscopy.
###end p 28
###begin title 29
Quantification of IgG levels
###end title 29
###begin p 30
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 64 70 <span type="species:ncbi:9986">rabbit</span>
###xml 76 81 <span type="species:ncbi:10090">mouse</span>
###xml 171 177 <span type="species:ncbi:10090">Murine</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 309 314 <span type="species:ncbi:10090">mouse</span>
Serum levels of total IgG were quantified with ELISA. In brief, rabbit anti-mouse IgG (Dako, Carpinteria, CA, USA) was coated on 96-well plates (Nunc, Roskilde, Denmark). Murine sera from naive and ZIA mice (dilution 1:100,000) were added and incubated for 2 hours. Secondary alkaline-phosphatase-linked anti-mouse IgG (Sigma, Buchs, Switzerland) was added and p-nitrophenyl phosphate (Sigma, Buchs, Switzerland) completed the reaction.
###end p 30
###begin p 31
###xml 136 142 <span type="species:ncbi:10090">murine</span>
Serum levels of specific anti-zymosan IgG were also quantified by ELISA. Zymosan particles at 1 mg/ml were coated on 96-well plates and murine sera (dilution 1:100) were added and incubated for 2 hours. The reaction was developed as previously described.
###end p 31
###begin title 32
Statistical analysis
###end title 32
###begin p 33
###xml 132 133 132 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 215 217 215 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The Wilcoxon rank sum test for unpaired variables (two-tailed) was used to compare differences between groups. The unpaired Student t-test was used to compare the groups with normally distributed values. A level of P < 0.05 was considered statistically significant.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
Zymosan-mediated inflammation in the knee joint is biphasic
###end title 35
###begin p 36
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 282 285 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 340 342 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
In experiments on WT C57bl/6 mice, we observed a biphasic course of inflammation, with an initial peak of 99mTc uptake at day 1 (1.71 +/- 0.08), followed by a decrease to a trough value at day 7 (1.29 +/- 0.05) and a secondary increase in uptake at day 14. Inflammation measured by 99mTc uptake persisted up to day 25 (1.40 +/- 0.06) (Fig. 1a).
###end p 36
###begin p 37
###xml 156 158 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 323 325 315 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Histological assessment of the mice at day 8 showed a low score for cellular infiltration (1.00 +/- 0.32) and for cartilage destruction (0.7 +/- 0.2) (Fig. 1b), whereas scoring at day 25 was characterized by an increase in cellular infiltration (2.5 +/- 0.37) while cartilage destruction remained low (0.71 +/- 0.24) (Fig. 1c).
###end p 37
###begin title 38
Histology and immune responses at day 25 of ZIA
###end title 38
###begin p 39
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
To determine whether zymosan particles persisted in the joint at day 25, periodic acid Schiff staining was performed on joint tissues obtained at day 25 and showed persistence of zymosan particles in the synovial membrane of mice injected with zymosan (Fig. 2a).
###end p 39
###begin p 40
###xml 361 363 361 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 497 499 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 330 334 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
To verify that joint inflammation was associated with the development of specific immune responses to zymosan, we assessed both humoral and cellular responses in WT mice. Proliferation of LNC in response to zymosan was significantly increased in day 25 WT ZIA mice compared with LNC of naive mice (3.5 stimulation index in ZIA WT mice versus 1.5 in naive mice; P < 0.001), whereas mitogenic response to the non-specific mitogen concanavalin A at 4 mug/ml showed no difference between groups (Fig. 2b). No difference in proliferation in response to zymosan was observed between ZIA and naive mice at day 8 (data not shown).
###end p 40
###begin p 41
###xml 263 265 263 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c</xref>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
The humoral response to zymosan was measured by ELISA. In arthritic mice, the serum levels of anti-zymosan IgG antibodies were significantly increased at day 25 in comparison with those in untreated naive mice (antibody ratio for WT = 0.944 versus naive = 0.677; P < 0.02) (Fig. 2c).
###end p 41
###begin p 42
###xml 13 22 13 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 196 198 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2d</xref>
In addition, in vitro stimulation of WT ZIA LNC with zymosan at 4 mug/ml induced the secretion of IFN-gamma at 1200 pg/ml, whereas unstimulated LNC produced undetectable levels of IFN-gamma (Fig. 2d).
###end p 42
###begin title 43
Synovial expression of TLR2 and its role in ZIA
###end title 43
###begin p 44
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b</xref>
###xml 458 462 458 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:10090">mice</span>
We wished next to evaluate whether TLR2 might have a role in the recognition of zymosan in vivo and in mediating inflammation in ZIA. Specific antibody for TLR2 was used to stain synovium from WT mice that had developed ZIA at day 25. Figure 3a shows a representative example of the distribution of TLR2 expression in the synovial cell lining. Control antibody staining was negative (Fig. 3b). Antibody specificity was confirmed by a lack of staining in TLR2-/- mice (data not shown).
###end p 44
###begin p 45
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 133 137 133 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 145 148 145 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
###xml 288 292 288 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 413 415 413 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
To explore whether the deficiency of TLR2 had an effect on the course of ZIA, we measured knee joint inflammation in TLR2+/+ and TLR2-/- mice by 99mTc uptake at different time points up to day 24 (Fig. 3c). In two independent experiments we observed an attenuation of inflammation in TLR2-/- mice at days 1, 3, 14, 17 and 24, although only the decrease observed at days 1 and 24 reached statistical significance (P < 0.05).
###end p 45
###begin title 46
TLR2 deficiency ameliorates histological features of ZIA
###end title 46
###begin p 47
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3d</xref>
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 354 358 354 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 435 439 435 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 465 469 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 475 477 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 510 514 506 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 520 522 516 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 561 563 557 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:10090">mice</span>
We compared the histological features of arthritic knee joints from TLR2+/+ and TLR2-/- mice (Fig. 3d). In both groups, arthritis was histologically present in all knees that had been injected with zymosan. In TLR2+/+ mice, on day 25 of ZIA, the synovial membrane was thickened, mainly as a result of invasion by inflammatory cells (see Fig. 1c). In TLR2-/- mice, synovial infiltrate was significantly decreased in comparison with TLR2+/+ mice (4.9 +/- 0.33 in TLR2+/+ mice [n = 15] versus 3.1 +/- 0.67 in TLR2-/- mice [n = 12] on day 25 after arthritis onset; P < 0.045).
###end p 47
###begin p 48
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3d</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
TLR2-/- mice showed no difference from WT mice in terms of cartilage destruction, as assessed by the loss of safranin-O staining at day 25 (Fig. 3d).
###end p 48
###begin title 49
Effect of TLR2 deficiency on cellular responses
###end title 49
###begin p 50
###xml 193 197 193 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 323 325 322 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 339 341 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3e</xref>
###xml 92 96 <span type="species:ncbi:10090">mice</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
The role of TLR2 on the cellular response to zymosan was examined by isolating LNC from ZIA mice. The proliferation of LNC induced by zymosan was significantly lower in cells isolated from TLR2-/- mice than in TLR2+/+ mice. A significant difference was found at both concentrations of zymosan studied (4 and 8 mug/ml; both P < 0.05) (Fig. 3e). No differences were observed in proliferation stimulated by the non-specific mitogen concanavalin A (data not shown).
###end p 50
###begin p 51
###xml 97 101 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 205 209 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 217 219 217 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3f</xref>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
The serum levels of anti-zymosan IgG antibodies, measured by ELISA, were decreased by 50% in TLR2-/- mice at day 25 in comparison with the serum levels in controls (antibody ratio for WT = 1.00 versus TLR2-/- = 0.51, P = 0.047) (Fig. 3f).
###end p 51
###begin title 52
Lack of effect of C3 on inflammation in ZIA
###end title 52
###begin p 53
###xml 129 132 129 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 200 202 200 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 241 243 241 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 312 316 312 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 322 326 322 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 326 330 <span type="species:ncbi:10090">mice</span>
The availability of C3-deficient mice in a C57bl/6 background allowed us to reassess the role of C3 in ZIA. No effect, either in 99mTc uptake or in histological scoring, was observed in C3-deficient (n = 25) mice in comparison with WT mice (n = 25). In addition, humoral and cellular responses were similar in C3-/- and C3+/+ mice (data not shown).
###end p 53
###begin p 54
###xml 74 78 74 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
###xml 456 458 454 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 518 520 514 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 558 560 554 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 574 576 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
Generation of TLR2/C3 double-deficient mice gave similar responses as TLR2-/- mice, excluding a synergistic effect of double deficiency and confirming no role for the alternative pathway component of the complement cascade (Fig. 4a). Histological scoring showed the presence of arthritis in both groups of animals. In TLR2/C-3 double-deficient mice, synovial infiltrate was significantly decreased in comparison with control (4.0 +/- 0.65 in control mice [n = 5] versus 1.9 +/- 0.62 in TLR2/C-3 double-deficient mice [n = 5] on day 25 after arthritis onset; P < 0.05) (Fig. 4b).
###end p 54
###begin p 55
###xml 159 161 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 221 223 217 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 229 231 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 245 247 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
###xml 215 219 <span type="species:ncbi:10090">mice</span>
TLR2/C-3 double-deficient mice also showed a significantly decreased cartilage destruction in comparison with WT mice at day 25 (1.7 +/- 0.12 in control mice [n = 5] versus 0.9 +/- 0.29 in TLR2/C-3 double-deficient mice [n = 5]; P < 0.05) (Fig. 4b).
###end p 55
###begin p 56
###xml 32 41 32 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 173 177 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
Stimulation of LNC with zymosan in vitro showed a significant decrease of stimulation in double-deficient mice compared with WT littermates, similar to that observed in TLR2-/- mice (data not shown).
###end p 56
###begin p 57
###xml 157 159 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4c</xref>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
In addition, a decreased production of zymosan-specific IgGs was observed in the double-deficient mice (ratio for WT = 0.944 versus double knockout = 0.616; P < 0.05) (Fig. 4c).
###end p 57
###begin title 58
Dectin-1 has a minor role in inflammation in ZIA
###end title 58
###begin p 59
###xml 98 107 95 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 151 159 148 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 167 176 164 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 458 460 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a</xref>
The identification of the beta-glucan receptor Dectin-1 and its ability to bind zymosan particles in vitro stimulated us to study the role of Dectin-1 in vivo in ZIA. In vitro blockade of the Dectin-1 receptor by laminarin led to a 50% decrease in a phagocytosis assay with RAW 264.7 cells. This decrease was not dependent on the time of administration of laminarin, because it was not modified by preincubation or co-incubation with zymosan particles (Fig. 5a).
###end p 59
###begin p 60
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Co-administration of laminarin and zymosan in the knee joint of C57bl/6 mice showed a trend to a decrease of 99mTc uptake in the early phase of inflammation in a laminarin-treated knee, compared with an untreated knee, at 4 hours and 1 day after administration, but did not reach statistical significance (Fig. 5b).
###end p 60
###begin title 61
Discussion
###end title 61
###begin p 62
###xml 183 191 183 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 474 476 474 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
For more than 50 years zymosan has been a tool in the study of microbial recognition by the innate immune system. The mechanisms mediating the recognition and phagocytosis of zymosan in vivo are complex. Phagocytes, including monocytes, macrophages and dendritic cells, express receptors such as the TLRs, complement receptor 3, scavenger receptors (such as acetylated LDL receptors) and Dectin-1 [22-24], which have all been implicated in the cellular response to zymosan [25]. In addition, zymosan is capable of activating the alternative pathway of complement through C3 [3], which may serve to amplify the inflammatory response.
###end p 62
###begin p 63
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 549 552 549 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
To elucidate how zymosan induces inflammation in vivo, we re-investigated the ZIA model that was first studied in the 1970s. This model has been often used as a tool to dissect non-immune mechanisms of joint inflammation [26-28]. In our experiments we observed that ZIA was not as short lived as originally described. Arthritis persisted beyond day 14 and in fact beyond day 25. After an initial peak of inflammation at about day 3, inflammation subsided by day 7. Subsequently, inflammation returned to levels that could be as high (as measured by 99mTc uptake) as the initial peak, suggesting that ZIA has early and late phases. Histologically, the joint inflammation was characterized by mononuclear cell infiltration in the sublining layer and hypertrophy of the lining layer as well as cartilage damage. Histological changes were milder at day 8 than at day 25. Zymosan particles were present in the synovium at day 25.
###end p 63
###begin p 64
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
We then investigated the role of TLR2 in ZIA because the macrophage inflammatory response to zymosan depends largely on its recognition by a heterodimer of TLR2 and TLR6 [2,10]. In TLR2-/- mice there was a significant attenuation of the early and late inflammatory phases of ZIA, indicating that a ligand that activates the innate immune response through TLR2 can lead to a chronic local inflammatory reaction.
###end p 64
###begin p 65
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 394 402 394 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 727 729 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1178 1181 1175 1178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 1529 1537 1526 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1538 1540 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
In the absence of TLR2, joint inflammation was not totally blocked. This would suggest that, in vivo, the inflammatory response to zymosan is not dependent on TLR2 signalling alone and that receptors other than TLR2 might have a role. This is supported by the observation that inhibition of TLR2 and MyD88 by dominant-negative mutants blocked pro-inflammatory signalling but not zymosan uptake in vitro. Recent data have shown that Dectin-1 and SIGNR1 [29] on macrophages and pentraxin-3, an opsonin for the recognition of zymosan by Dectin-1, are involved in zymosan recognition and internalization [30]. We therefore investigated the role of Dectin-1 by using the beta-glucan laminarin as a competitive inhibitor of zymosan [16]. We confirmed that laminarin inhibited zymosan uptake by RAW 264.7 cells and did not observe any difference in the blocking capacity of laminarin, whether administered before or at the same time as zymosan. In both cases and at two different concentrations, we observed a 50% decrease in cell-bound zymosan particles. On the basis of these results, we proceeded to assess the effect of laminarin on ZIA. Although there was a trend towards reduced 99mTc uptake in the treated animals, this was not statistically significant. It is possible that 50% inhibition of zymosan phagocytosis is insufficient to modulate inflammatory signalling through TLR2. Furthermore, a redundancy in the multiple mechanisms that mediate zymosan phagocytosis could also explain the lack of effect of laminarin inhibition in vivo [31].
###end p 65
###begin p 66
###xml 239 243 239 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 486 490 482 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1182 1186 1178 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1301 1303 1297 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1388 1390 1384 1386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
The biphasic course of ZIA and its modulation by TLR2 led us to study the acquired immune response to zymosan and the effects of TLR2 deficiency on it. We compared the cellular proliferative and antibody responses to zymosan in WT and TLR2-/- mice at day 25. First, we were able to detect zymosan-induced lymphocyte proliferation and enhanced IFN-gamma production in the draining LNC of mice with ZIA, and second, this was accompanied by the formation of a zymosan-specific IgG. In TLR2-/- animals, the proliferative response was blunted and only reached 50% of that observed in WT ZIA animals. There was also a significant decrease in the zymosan-specific IgG response, which was about 50% lower than in WT mice. At day 8 we did not observe any difference between ZIA and naive WT mice in their proliferative response to zymosan (data not shown). These findings suggest that inflammation in the later phase of ZIA is paralleled by the development of acquired immune response to zymosan. The finding that zymosan particles persisted in the joint even at day 25 suggests that they could become a target for specific immune responses. The decrease in acquired immune responses in TLR2-/- mice might be a result of the decreased antigen presentation efficiency of dendritic cells in the absence of TLR2 [32] or the lack of co-stimulatory signals through TLR2 expressed on activated T cells [33].
###end p 66
###begin p 67
###xml 135 139 135 139 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 310 313 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 346 350 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 505 509 505 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 596 600 596 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 898 905 898 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 213 217 <span type="species:ncbi:10090">Mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
A significant role for the alternative pathway of complement in this model of inflammation was excluded by the phenotype observed in C3-/- mice. Both phases of ZIA were comparable to that observed in WT controls. Mice with combined deletions of the C3 and the TLR2 genes did not show a significant decrease in 99mTc uptake in comparison with TLR2-/- mice. Histologically, we observed a significant decrease in cartilage damage in mice with the combined deficiency of TLR2 and C3, which did not occur in C3-/- mice. We interpret this effect to be due in principle to the lack of TLR2, because TLR2-/- mice also showed a diminished cartilage score (although it did not reach statistical significance). Combined with recent data showing that phagocytosis of zymosan is not mediated by complement receptor 3 [16], complement activation does not seem to contribute to zymosan-induced joint inflammation in vivo.
###end p 67
###begin p 68
###xml 123 127 123 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 506 508 506 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 622 624 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 316 328 <span type="species:ncbi:9606">participants</span>
###xml 384 389 <span type="species:ncbi:9606">human</span>
###xml 1295 1298 <span type="species:ncbi:9606">man</span>
The expression of TLR2 in arthritic synovium from WT mice in the ZIA model and the modulation of joint inflammation in TLR2-/- animals show that TLR2 may have a general role in amplifying local inflammation. TLR2 has been shown to be expressed on neutrophils and lymphocytes as well as macrophages, and they all are participants in the inflammatory process in this model. The data in human arthritis would also support such a role for TLR2. Increased expression of TLR2 in synovial lining layer and by CD16+ peripheral blood mononuclear cells in RA indicate that its expression is upregulated during chronic inflammation [34]. TLR2 is also expressed on RA synovial fibroblasts, and incubation of cultured RA synovial fibroblasts with pro-inflammatory cytokines increases levels of TLR2 mRNA [35]. Although the precise role of TLR signalling in RA is unclear at present, increased TLR2 expression might modulate synovial inflammation if endogenous or exogenous TLR2 ligands gain access to the joint, thus amplifying specific and innate immune pathways of synovial inflammation. Furthermore, our results provide a model by which stimulation of the innate immune response can lead to chronic inflammation in the joint. These pathways may be of relevance to the development of reactive arthritis in man.
###end p 68
###begin title 69
Conclusion
###end title 69
###begin p 70
###xml 416 419 <span type="species:ncbi:9606">man</span>
The results of the present study indicate that the biphasic joint inflammation in ZIA is mediated primarily by activation of the innate immune system. In the early phase of arthritis TLR2 plays a vital role, and in the later phase the development of a secondary immune response to zymosan may contribute to joint inflammation. Innate immune responses may be important amplificatory pathways of joint inflammation in man.
###end p 70
###begin title 71
Abbreviations
###end title 71
###begin p 72
ELISA = enzyme-linked immunosorbent assay; IFN = interferon; IL = interleukin; LNC = lymph node cells; TLR = Toll-like receptor; WT = wild-type; ZIA = zymosan-induced arthritis.
###end p 72
###begin title 73
Competing interests
###end title 73
###begin p 74
The author(s) declare that they have no competing interests.
###end p 74
###begin title 75
Authors' contributions
###end title 75
###begin p 76
MF contributed to breeding and genotyping, performed technetium uptake measurements and immunoassays, and participated in coordination of the study. DT participated in technetium uptake measurements. VC performed histological stainings and scoring. NB performed statistical analysis and participated in the design of the study. AS conceived of the study, participated in its design and coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 76
###begin title 77
Acknowledgements
###end title 77
###begin p 78
###xml 106 110 106 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 390 394 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
We thank Professor Marina Botto (Division of Medicine, Imperial College London, UK) for the gift of the C3-/- mice, and Dr Didier Le Roy (Laboratoire de Maladies Infectieuses, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland) and Professor Kiyoshi Takeda (Department of Host Defense, Research Institute for Microbial Diseases, Osaka University) for providing us with the TLR2-/- mice.
###end p 78
###begin article-title 79
On the composition of Zymosan
###end article-title 79
###begin article-title 80
The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
###end article-title 80
###begin article-title 81
Activation of the alternative complement pathway due to resistance of zymosan-bound amplification convertase to endogenous regulatory mechanisms
###end article-title 81
###begin article-title 82
Macrophage recognition of zymosan particles
###end article-title 82
###begin article-title 83
Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement
###end article-title 83
###begin article-title 84
Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation
###end article-title 84
###begin article-title 85
###xml 25 36 25 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 25 35 <span type="species:ncbi:7227">Drosophila</span>
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
###end article-title 85
###begin article-title 86
Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
###end article-title 86
###begin article-title 87
Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
###end article-title 87
###begin article-title 88
The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors
###end article-title 88
###begin article-title 89
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Early IL-2 production by mouse dendritic cells is the result of microbial-induced priming
###end article-title 89
###begin article-title 90
Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning
###end article-title 90
###begin article-title 91
The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages
###end article-title 91
###begin article-title 92
Immune recognition: a new receptor for beta-glucans
###end article-title 92
###begin article-title 93
Dectin-1 is a major beta-glucan receptor on macrophages
###end article-title 93
###begin article-title 94
Dectin-1 mediates the biological effects of beta-glucans
###end article-title 94
###begin article-title 95
###xml 46 50 <span type="species:ncbi:10090">mice</span>
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity
###end article-title 95
###begin article-title 96
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
###end article-title 96
###begin article-title 97
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake
###end article-title 97
###begin article-title 98
Receptor binding and internalization of a water-soluble (1--> 3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines
###end article-title 98
###begin article-title 99
Specificity of membrane complement receptor type three (CR3) for beta-glucans
###end article-title 99
###begin article-title 100
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human monocyte scavenger receptors are pattern recognition receptors for (1--> 3)-beta-D-glucans
###end article-title 100
###begin article-title 101
###xml 132 137 <span type="species:ncbi:9606">human</span>
A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes
###end article-title 101
###begin article-title 102
The effects of laminarin, sulfated glucan and oligosaccharides of glucan on reticuloendothelial activity
###end article-title 102
###begin article-title 103
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice
###end article-title 103
###begin article-title 104
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Immune complexes, but not streptococcal cell walls or zymosan, cause chronic arthritis in mouse strains susceptible for collagen type II auto-immune arthritis
###end article-title 104
###begin article-title 105
###xml 154 160 <span type="species:ncbi:10090">murine</span>
Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis
###end article-title 105
###begin article-title 106
###xml 92 97 <span type="species:ncbi:4932">yeast</span>
The role of SIGNR1 and the beta-glucan receptor (dectin-1) in the nonopsonic recognition of yeast by specific macrophages
###end article-title 106
###begin article-title 107
PTX3 function as an opsonin for the dectin-1-dependent internalization of zymosan by macrophages
###end article-title 107
###begin article-title 108
Phagocytosis of microbes: complexity in action
###end article-title 108
###begin article-title 109
Dendritic cells and the control of immunity
###end article-title 109
###begin article-title 110
TLR2 is expressed on activated T cells as a costimulatory receptor
###end article-title 110
###begin article-title 111
Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis
###end article-title 111
###begin article-title 112
Expression and regulation of Toll-like receptor 2 in rheumatoid arthritis synovium
###end article-title 112
###begin title 113
Figures and Tables
###end title 113
###begin p 114
###xml 69 73 69 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 338 340 338 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 528 532 526 530 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 693 695 687 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 738 742 732 736 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 862 864 852 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
Biphasic kinetic of inflammation in zymosan-induced arthritis (ZIA). (a) 99mTc uptake measurement shows a biphasic course of inflammation in wild-type (WT) mice. Zymosan was injected into the right knee and PBS was injected into the contralateral control knee. The values obtained correspond to the ratio between the right and left knee (n = 15). The severity of histological signs of arthritis was assessed by scoring synovial thickness and cartilage destruction on a scale from 0 to 6. Results are expressed as means +/- SEM. (b) WT mice with ZIA showed mild inflammation at day 8 as judged by cellular infiltration (histological score 1.00 +/- 0.32) and cartilage destruction (0.7 +/- 0.2; n = 10), which became more severe at day 25. (c) There was an increase in cellular infiltration (2.5 +/- 0.37) but cartilage destruction remained slight (0.71 +/- 0.21; n = 10). The arrows in (b) and (c) indicate inflammatory infiltrate in the synovial membrane.
###end p 114
###begin p 115
###xml 49 53 49 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 228 232 228 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 232 241 232 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 462 466 461 465 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 760 762 759 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 771 775 770 774 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 546 550 <span type="species:ncbi:10090">mice</span>
###xml 706 712 <span type="species:ncbi:10090">murine</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
Local and immune responses to zymosan at day 25. (a) Periodic acid Schiff staining shows the persistence of zymosan particles (arrow) within the synovial membrane in zymosan-induced arthritis (ZIA). Original magnification x100. (b) In vitro lymph node mononuclear cell proliferation in response to zymosan at day 25 of ZIA and in naive mice. Single-cell suspensions were incubated with 4 mug/ml zymosan. Concanavalin A (ConA) was used as a non-specific mitogen. (c) Antibody production against zymosan in zymosan-treated mice compared with naive mice measured by enzyme-linked immunosorbent assay (ELISA). The results are expressed as a ratio of the amount of zymosan-specific IgGs (in arbitrary units) in murine serum to total IgGs (also in arbitrary units) (P < 0.05). (d) Interferon-gamma (IFN-gamma) production by zymosan-stimulated and unstimulated lymph node cells of WT ZIA and naive mice in culture. IFN-gamma was measured by specific ELISA. n.d., not detectable.
###end p 115
###begin p 116
###xml 75 79 75 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 284 288 284 288 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 373 377 373 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 377 380 377 380 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 471 473 471 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 488 492 488 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 502 504 502 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 536 538 536 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 628 632 628 632 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 728 732 728 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 738 740 738 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 834 838 834 838 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 927 931 926 930 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f) </bold>
###xml 990 994 989 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1002 1006 1001 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 329 335 <span type="species:ncbi:9913">bovine</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 530 534 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 1006 1010 <span type="species:ncbi:10090">mice</span>
TLR2 mediates an inflammatory response in zymosan-induced arthritis (ZIA). (a) Immunohistochemistry of TLR2 expression in synovial membrane sections of WT mice (day 25 ZIA) showed staining in the sublining (sl) of synovial membrane, whereas inflammatory lymphocytes were not stained. (b) Negative control was performed with 0.5% bovine serum albumin. (100x magnification). (c) 99mTc uptake measurement showed an attenuation of the inflammatory response at days 1 and 25 (P < 0.05) in TLR2-/- ZIA mice (n = 5) compared with WT ZIA mice (n = 5). The technetium ratio was measured as detailed in the Materials and methods section. (d) Histological scoring at day 25 of ZIA showed a significant decrease in cell infiltration in TLR2-/- mice (P < 0.02) compared with control mice, whereas cartilage destruction was similar in both groups. (e) Lymph node cell proliferation to 4 and 8 mug/ml zymosan (Zym 4 and Zym 8, respectively). (f) Antibody production against zymosan in zymosan-treated TLR2+/+ and TLR2-/- mice.
###end p 116
###begin p 117
###xml 81 85 81 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 217 219 217 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 266 268 266 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 317 321 317 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 399 401 399 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 436 438 436 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 481 483 481 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 522 524 522 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 530 534 530 534 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 475 479 <span type="species:ncbi:10090">mice</span>
###xml 607 611 <span type="species:ncbi:10090">mice</span>
C3 has no role in mediating inflammatory responses in zymosan-induced arthritis. (a) 99mTc uptake measurement showed an attenuation of inflammation at early and late time points in TLR2/C3 double-deficient (KO) mice (n = 5) compared with double wild-type (WT) mice (n = 5) but did not reach statistical significance. (b) Histological scoring showed a significant decrease in both cell infiltration (P < 0.05) and cartilage destruction (P < 0.05) in TLR2/C-3 double-deficient mice (n = 5) compared with littermate control (n = 5). (c) Production of specific anti-zymosan IgGs was reduced in double-deficient mice in comparision with double WT littermates. Values correspond to the ratio of zymosan-specific IgG to total IgG mentioned in Fig. 2c.
###end p 117
###begin p 118
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 42 46 42 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 79 81 79 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 129 131 129 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 490 492 484 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 501 505 495 499 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 635 637 626 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 720 723 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 773 776 763 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">99m</sup>
###xml 805 807 795 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n </italic>
###xml 629 633 <span type="species:ncbi:10090">mice</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 942 946 <span type="species:ncbi:10090">mice</span>
Dectin-1 inhibition in vitro and in vivo. (a) In a phagocytosis assay, 2.5 x 106 particles of zymosan were incubated with 10 x 105 RAW 264.7 cells. Laminarin was administered either before (pre adm.) or at the same time as (co adm.) the zymosan particles. Incubation of zymosan particles was performed for 4 hours at 37degreesC. Laminarin decreased the amount of zymosan bound to and phagocytosed by RAW 264.7 cells by 50% in comparison with a control to which no laminarin had been added (P < 0.05). (b) Laminarin (500 mug) and zymosan (180 mug) in a final volume of 15 mul were co-injected into the right knee joint of C57bl/6 mice (n = 6). Phosphate-buffered saline (15 mul) was injected into the contralateral knee. 99mTc uptake was measured up to day 7. Comparison of 99mTc uptake with control mice (n = 8), which received zymosan alone in the right knee, showed an attenuation of inflammation at 4 and 24 hours in the laminarin-treated mice, but did not reach statistical significance. After 72 hours the values were similar.
###end p 118

